RSC Advances
Page 8 of 10
DOI: 10.1039/C5RA05468K
13C NMR (100 MHz, CDCl3): δc 157.3, 137.1, 134.0, 127.7,
65 127.4, 126.9, 126.8, 60.8, 52.3, 13.1.
General procedure for the synthesis of propargylamine
derivatives (7aꢀj):
In a 25 mL glass vial, a mixture of benzaldehydes 4aꢀj (1mmol),
134.6, 129.1, 128.8, 128.1, 122.5, 66.8, 54.2, 53.7, 53.4; MS m/z
= 259 M++1; Anal. Calcd for C14H18N4O (258.15): C, 65.09; H,
7.02; N, 21.69. Found: C, 65.02; H, 7.05; N, 21.75.
1ꢀ((1ꢀbenzylꢀ1Hꢀ1, 2, 3ꢀtriazoleꢀ4ꢀyl) methyl) indolineꢀ2,3ꢀ
5
dione (3f): Orange solid; Mp = 134ꢀ136 °C; Rf = 0.12 (30 %
1
Ethylacetate: nꢀhexane); H NMR (400 MHz, CDCl3): δH 7.60ꢀ
amine 5a, 5b (1.2 mmol), phenylacetylene 6 (1.5 mmol) and LCO
70 nanoparticles (10 mg) in 5mL toluene, were sonicated for 30 min.
The progress of the reaction was monitored by TLC (20% ethyl
acetate/hexane). After completion of the reaction, the catalyst was
removed by centrifugation. The reaction mixture was extracted
with ethyl acetate (3×10 mL). The combined organic phases were
75 dried with Na2SO4, filtered, concentrated, and the residue was
purified by flash chromatography on silica gel (elutant:
hexane/ethyl acetate, 3:1, v/v).
7.56 (m, 2H), 7.52 (s, 1H), 7.37ꢀ7.35 (m, 2H), 7.32 (d, J = 8.0 Hz,
1H), 7.25ꢀ7.23 (m, 2H), 7.11 (t, J = 7.2 Hz, 1H), 5.48 (s, 2H),
4.99 (s, 2H); 13C NMR (100 MHz, CDCl3): δc 183.1, 157.9,
10 150.2, 142.1, 138.6, 134.0, 129.2, 129.0, 128.3, 125.3, 124.0,
122.8, 117.5, 111.6, 54.4, 35.4. HRMS: calculated for
C18H14N4O2 Mw: 318.1117, found: 318.1115.
1ꢀ(4ꢀnitrobenzyl)ꢀ4ꢀphenylꢀ1Hꢀ1, 2, 3ꢀtriazole (3g):39b White
solid; Mp = 114ꢀ116 °C; Rf = 0.25 (30 % Ethylacetate: nꢀ
15 hexane); 1H NMR (400 MHz, CDCl3): δH 8.26ꢀ8.23 (m, 2H), 7.82
(d, J = 6.8, 2H), 7.75 (s, 1H), 7.46ꢀ7.40 (m. 4H), 7.36ꢀ7.32 (m,
1H), 5.70 (s, 2H). 13C NMR (100 MHz, CDCl3): δc 148.1, 141.7,
130.1, 128.9, 128.6, 128.5, 125.8, 124.4, 119.7, 53.2.
4ꢀ(1,3ꢀdiphenylpropꢀ2ꢀynꢀ1ꢀyl)morpholine (7a):40a,b Viscous
liquid; 1H NMR (400 MHZ, CDCl3): δH 7.64ꢀ7.62 (m, 2H), 7.53ꢀ
80 7.50 (m, 2H), 7.39ꢀ7.24 (m, 6H), 4.79 (s, 1H), 3.78ꢀ3.69 (m, 4H),
2.64ꢀ2.62 (m, 4H); 13C NMR (100 MHz, CDCl3): δc 137.8,
131.8, 128.6, 128.3, 128.28, 128.2, 127.8, 123.0, 88.5, 85.1, 67.2,
62.1, 49.9.
1ꢀ(4ꢀmethoxybenzyl)ꢀ4ꢀphenylꢀ1Hꢀ1, 2, 3ꢀtriazole (3h):39c
20 White solid; Mp = 128ꢀ130 °C; Rf = 0.45 (30 % Ethylacetate: nꢀ
1
hexane); H NMR (400 MHz, CDCl3): δH 7.78 (d, J = 7.2 Hz,
2H), 7.62 (s, 1H), 7.39 (t, J = 7.6 Hz, 2H), 7.32ꢀ7.25 (m, 3H),
6.90 (d, J = 8.8, 2H), 5.49 (s, 2H), 3.80 (s, 3H); 13C NMR (100
MHz, CDCl3): δc 159.9, 148.1, 130.6, 129.7, 128.8, 128.1, 126.7,
25 125.7, 119.3, 114.5, 55.4, 53.8.
4ꢀ(3ꢀphenyl)ꢀ1ꢀ(pꢀtolyl)propꢀ2ꢀynꢀ1ꢀyl)morpholine
(7b):40c
1
85 Viscous liquid; H NMR (400 MHZ, CDCl3): δH 7.32ꢀ7.30 (m,
4H), 7.23ꢀ7.21 (m, 3H), 7.17 (d, J = 8.0 Hz, 2H), 4.74 (s, 1H),
3.74ꢀ3.72 (m, 4H), 2.63ꢀ2.61 (m, 4H), 2.35 (s, 3H); 13C NMR
(100 MHz, CDCl3): δc 137.5, 134.9, 131.8, 128.9, 128.6, 128.3,
128.2, 123.1, 88.3, 85.4, 67.2, 61.8, 49.9, 21.2.
1ꢀ(4ꢀchlorobenzyl)ꢀ4ꢀphenylꢀ1Hꢀ1, 2, 3ꢀtriazole (3i):39d White
solid; Mp = 132ꢀ134 °C; Rf = 0.5 (30 % Ethylacetate: nꢀhexane);
1H NMR (400 MHz, CDCl3): δH 7.80 (d, J = 7.2 Hz, 2H), 7.67 (s,
1H), 7.42ꢀ7.30 (m, 5H), 7.24 (d, J = 8.4 Hz, 2H), 5.54 (s, 2H);
30 13C NMR (100 MHz, CDCl3): δc 134.9, 133.2, 130.5, 129.5,
129.4, 129.0, 128.9, 128.3, 125.7, 119.5, 53.5.
90 4ꢀ(1ꢀ(4ꢀmethoxyphenyl)ꢀ3ꢀphenylpropꢀ2ꢀynꢀ1ꢀyl)morpholine
1
(7c):40d Viscous liquid; H NMR (400 MHZ, CDCl3): δH 7.51ꢀ
1ꢀbenzylꢀ4,5ꢀdiphenylꢀ1Hꢀ1, 2, 3ꢀtriazole (3j):39e White solid;
Mp = 82ꢀ86 °C; Rf = 0.5 (30 % Ethylacetate: nꢀhexane); 1H NMR
(400 MHz, CDCl3): δH 7.55 (d, J = 6.8 Hz, 2H), 7.46 (d, J = 6.8
35 Hz, 1H), 7.41 (t, J = 7.6 Hz, 2H), 7.25ꢀ7.22 (m, 6H), 7.14 (d, J =
7.2 Hz, 2H), 7.03ꢀ7.01 (m, 2H), 5.40 (s, 2H); 13C NMR (100
MHz, CDCl3): δc 144.6, 139.4, 135.5, 133.9, 131.0, 130.2, 129.8,
129.3, 128.8, 128.5, 128.2, 127.9, 127.6, 126.8, 52.1.
7.49 (m, 4H), 7.33ꢀ7.31(m, 3H), 6.91ꢀ6.89 (m, 2H), 4.73(s, 1H)
3.81 (s, 3H), 3.74ꢀ3.71 (m, 4H), 2.63ꢀ2.59 (m, 4H); 13C NMR
(100 MHz, CDCl3): δc 171.1, 159.2, 131.8, 129.9, 129.7, 128.3,
95 123.0, 113.6, 88.3, 85.4, 67.2, 61.5, 55.3, 49.8.
4ꢀ(1ꢀ(4ꢀbromophenyl)ꢀ3ꢀphenylpropꢀ2ꢀynꢀ1ꢀyl)morpholine
1
(7d):40e Viscous liquid; H NMR (400 MHZ, CDCl3): δH 7.53ꢀ
4ꢀphenylꢀ1ꢀ(thiophenꢀ2ꢀylmethyl)ꢀ1Hꢀ1, 2, 3ꢀtriazole (3k):39f
7.47 (m, 6H), 7.34ꢀ7.32 (m, 3H), 4.74 (s, 1H), 3.76ꢀ3.68 (m. 4H),
2.62ꢀ2.59 (m, 4H); 13C NMR (100 MHz, CDCl3): δc 137.0,
100 131.8, 131.4, 130.3, 128.5, 128.4, 122.7, 121.8, 88.9, 84.3, 67.1,
61.5, 49.8.
40 White solid; Mp = 104ꢀ106 °C; Rf = 0.38 (20 % Ethylacetate: nꢀ
hexane); H NMR (400 MHZ, CDCl3): δH 7.71 (d, J = 7.2 Hz,
1
2H), 7.64 (s, 1H), 7.33ꢀ7.29 (m, 2H), 7.25ꢀ7.22 (m, 2H), 7.05ꢀ
7.04 (m, 1H), 6.93ꢀ6.91(m, 1H), 5.64 (s, 2H); 13C NMR (100
MHz, CDCl3): δc 147.2, 135.1, 129.5, 127.8, 127.2, 127.1, 126.3,
45 126.1, 124.7, 118.2, 47.5.
4ꢀ(1ꢀ(4ꢀchlorophenyl)ꢀ3ꢀphenylpropꢀ2ꢀynꢀ1ꢀyl)morpholine
(7e):40e Viscous liquid; 1H NMR (400 MHZ, CDCl3): δH 7.50 (d,
J = 8.4 Hz, 2H), 7.44ꢀ7.41 (m, 2H), 7.26ꢀ7.24 (m, 5H), 4.67(s,
105 1H) 3.66ꢀ3.64 (m, 4H), 2.54ꢀ2.51 (m, 4H); 13C NMR (100 MHz,
CDCl3): δc 136.5, 133.6, 131.8, 129.9, 128.4, 128.4, 122.7, 88.9,
84.4, 67.1, 61.4, 49.8.
1ꢀoctylꢀ4ꢀphenylꢀ1Hꢀ1, 2, 3ꢀtriazole (3l):39g White solid; Mp =
1
62ꢀ64 °C; Rf = 0.5 (20 % Ethylacetate: nꢀhexane); H NMR (400
MHZ, CDCl3): δH 7.75 (d, J = 7.6 Hz, 2H), 7.67 (s, 1H), 7.34 (t, J
= 7.2 Hz, 2H), 7.26ꢀ7.22 (m, 1H), 4.29 (t, J = 7.6 Hz, 2H), 1.86ꢀ
50 1.83 (m, 2H), 1.26ꢀ1.18 (m, 10H), 0.79 (t, J = 7.2 Hz, 3H); 13C
NMR (100 MHz, CDCl3): δc 147.7, 130.8, 128.8, 128.1, 125.7,
119.4, 50.4, 31.7, 30.4, 29.1, 28.9, 26.5, 22.6, 14.1.
1ꢀ(3ꢀphenylꢀ1ꢀ(pꢀtolyl)propꢀ2ꢀynꢀ1ꢀyl)piperidine
(7g):40f
1
Viscous liquid; H NMR (400 MHZ, CDCl3): δH 7.51ꢀ7.49 (m,
110 4H), 7.31ꢀ7.30 (m, 3H), 7.17ꢀ7.15 (m, 2H), 4.75 (s, 1H), 2.60ꢀ
2.52 (m, 4H), 2.35 (s, 3H) 1.62ꢀ1.53 (m, 4H), 1.44ꢀ1.42 (m, 2H);
13C NMR (100 MHz, CDCl3): δc 137.1, 135.6, 131.8, 128.8,
128.5, 128.3, 128.0, 123.5, 87.6, 86.4, 62.2, 50.7, 26.2, 24.5,
21.2.
1ꢀhexylꢀ4ꢀphenylꢀ1Hꢀ1, 2, 3ꢀtriazole (3m):39f White solid; Mp =
72ꢀ74 °C; Rf = 0.55 (20 % Ethylacetate: nꢀhexane); 1H NMR (400
55 MHZ, CDCl3): δH 7.75 (d, J = 6.8 Hz, 2H), 7.67 (s, 1H), 7.34 (t, J
= 7.6 Hz, 2H), 7.26ꢀ7.22 (m, 1H), 4.30 (t, J = 7.2 Hz, 2H), 1.89ꢀ
1.82 (m, 2H), 1.29ꢀ1.21 (m, 6H), 0.81 (t, J = 7.2 Hz, 3H); 13C
NMR (100 MHz, CDCl3): δc 146.7, 129.7, 127.8, 127.0, 124.7,
118.3, 49.4, 30.1, 29.3, 25.1, 21.4, 12.9.
115 1ꢀ(1ꢀ(4ꢀmethoxyphenyl)ꢀ3ꢀphenylpropꢀ2ꢀynꢀ1ꢀyl)piperidine
1
(7h):40g Viscous liquid; H NMR (400 MHZ, CDCl3): δH 7.54ꢀ
7.49 (m, 4H), 7.32ꢀ7.30 (m, 3H), 6.88 (d, J = 7.6 Hz, 2H), 4.78 (s,
1H), 3.80 (s, 3H), 2.59ꢀ2.57 (m, 4H), 1.65ꢀ1.54 (m, 4H), 1.44ꢀ
1.42 (m, 2H); 13C NMR (100 MHz, CDCl3): δc 159.1 132.0,
120 131.8, 129.8, 128.3, 128.1, 114.3, 113.4, 87.7, 86.2, 61.7, 55.3,
50.5, 26.0, 24.4.
60 Ethylꢀ1ꢀbenzylꢀ1Hꢀ1,2,3ꢀtriazoleꢀ4ꢀcarboxylate (3n):39g White
solid; Mp = 82ꢀ86 °C; Rf = 0.15 (20 % Ethylacetate: nꢀhexane);
1H NMR (400 MHZ, CDCl3): δH 8.05 (s, 1H), 7.26ꢀ7.19 (m, 5H),
5.83 (s, 2H), 4.26 (q, J = 7.2 Hz, 2H), 1.26 (t, J = 7.2 Hz, 3H);
1ꢀ(1ꢀ(4ꢀbromophenyl)ꢀ3ꢀphenylpropꢀ2ꢀynꢀ1ꢀyl)piperidine
8
| Journal Name, [year], [vol], 00–00
This journal is © The Royal Society of Chemistry [year]